首页 | 本学科首页   官方微博 | 高级检索  
检索        

内镜注射硬化疗法联合部分脾栓塞术治疗门脉高压症的临床疗效
引用本文:孔宪和,陈晓春.内镜注射硬化疗法联合部分脾栓塞术治疗门脉高压症的临床疗效[J].岭南现代临床外科,2010,10(3).
作者姓名:孔宪和  陈晓春
作者单位:东莞市人民医院消化科,广东东莞,523000
摘    要:目的对内镜注射硬化疗法(EIS)联合部分脾栓塞(PSE)治疗肝硬化门脉高压的疗效进行评价。方法对我科于2005年2月至2008年11月收治22例食道胃底静脉曲张合并脾功能亢进的门脉高压患者采用内镜硬化剂注射联合部分脾栓塞的治疗进行回顾性分析。术后定期随访和比较术前术后的消化道出血、肝功能评级及外周血象的变化。结果 EIS平均次数1.8次,所有患者均行1次PSE治疗。术后随访5-30个月,无严重并发症出现,未见有再出血,肝功能部分改善,外周血血小板和白细胞计数明显升高(P<0.05)。结论 EIS联合PSE方法对肝硬化所致的食管胃底静脉曲张出血和门脉高压症是安全有效的。

关 键 词:内镜注射硬化疗法  部分脾栓塞术  门脉高压症

Clinical efficacy on endoscopic injected sclerosing agent combined with partial splenic embolization for treating sclerotic portal hypertension
Kong Xianhe,Chen Xiaochun.Clinical efficacy on endoscopic injected sclerosing agent combined with partial splenic embolization for treating sclerotic portal hypertension[J].Lingnan Modern Clinics in Surgery,2010,10(3).
Authors:Kong Xianhe  Chen Xiaochun
Institution:Kong Xianhe; Chen Xiaochun.Department of Gastroenterology; Dong Guan People s Hospital; Guangdong 523000;
Abstract:Objective To evaluate the clinical efficacy on endoscopic injected sclerosing agent(EIS)combined with partial splenic embolization(PSE)in the treatment of sclerotic portal hypertension.Methods From February 2005 to November 2008,EIS-PSE was performed in twenty-two patients with portal hypertension complicated by gastroesophageal varices and hypersplenism.All cases were regularly followed up.The changes in upper gastrointestinal bleeding,level of hepatic function and peripheral blood cell counts were compare...
Keywords:Endoscopic injection sclerotherapy(EIS)  Partial splenic embolization(PSE)  Portal hypertension
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号